Market Closed -
Other stock markets
|
After market 03:26:07 pm | |||
49.9 EUR | -0.99% | 49.98 | +0.15% |
May. 23 | Ailing hospitals slow down German medical technology sector | DP |
May. 01 | DRÄGERWERK AG & CO KGAA : China weighs on Q1 24 growth |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's attractive earnings multiples are brought to light by a P/E ratio at 10.03 for the current year.
- The company shows low valuation levels, with an enterprise value at 0.29 times its sales.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company has a low valuation given the cash flows generated by its activity.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.67% | 977M | B+ | ||
+8.45% | 222B | B | ||
+24.14% | 148B | B- | ||
+33.09% | 114B | A- | ||
+4.45% | 65.69B | A- | ||
+14.38% | 51.88B | B+ | ||
+4.08% | 50.02B | B+ | ||
-4.66% | 38.81B | A | ||
-3.19% | 34.59B | - | ||
+22.84% | 31.09B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DRW3 Stock
- Ratings Drägerwerk AG & Co. KGaA